Company: ICUI
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0000883984-25-000035
Chunk: 60

Company: ICU MEDICAL INC/DE
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 1
Chunk 60
---
 balance, January 1, 2025$39,403 Equipment revenue recognized(46,677)Equipment revenue deferred due to implementation51,563 Software revenue recognized(8,758)Software revenue deferred due to implementation4,293 Government grant income recognized(1) (1,545)Other deferred revenue recognized(1,712)Other deferred revenue 646 Ending balance, September 30, 2025$37,213 Beginning balance, January 1, 2024$42,177 Equipment revenue recognized(41,392)Equipment revenue deferred due to implementation38,825 Software revenue recognized(23,591)Software revenue deferred due to implementation24,559 Government grant income recognized(1) (1,551)Other deferred revenue recognized(2,562)Other deferred revenue503 Ending balance, September 30, 2024$36,968 ____________________________(1) The government grant income deferred is amortized over the life of the related depreciable asset as a reduction to depreciation expense.  Our contract liabilities are included in accrued liabilities or other long-term liabilities in our condensed consolidated balance sheet based on the expected timing of revenue recognition.    As of September 30, 2025, revenue from remaining performance obligations is as follows:Recognition Timing(in thousands)< 12 Months> 12 MonthsEquipment deferred revenue$20,341 $403 Software deferred revenue5,884 2,072 Government grant deferred income(1) 2,064 5,798 Other deferred revenue(2) 611 40 Total $28,900 $8,313 _________________________________(1) The government grant deferred income is amortized over the life of the related depreciable asset as a reduction to depreciation expense.(2) Other deferred revenue includes pump development programs, purchased training and extended warranty.

Note 6: Segment Data

The Company has a single operating and reportable segment. The Company derives revenues from the manufacture and sale of our medical products which are used in infusion therapy, vascular access, and vital care applications. Our product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, IV catheters, sharps safety products, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management 

16

ICU MEDICAL, INC. AND SUB